{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:11:50Z","timestamp":1748664710179,"version":"3.41.0"},"reference-count":55,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780081000946"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/b978-0-08-100094-6.00020-1","type":"book-chapter","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T20:40:58Z","timestamp":1443818458000},"page":"357-371","source":"Crossref","is-referenced-by-count":0,"title":["Correlation between cell- and tissue-based in vitro models for\u00a0drug permeability screening with in vivo situation"],"prefix":"10.1016","author":[{"given":"Paulo","family":"Paix\u00e3o","sequence":"first","affiliation":[]},{"given":"Lu\u00eds","family":"Gouveia","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Augusto","family":"Guimar\u00e3es Morais","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Silva","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/B978-0-08-100094-6.00020-1_bib1","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0169-409X(01)00179-X","article-title":"Predicting the impact of physiological and biochemical processes on oral drug bioavailability","volume":"50","author":"Agoram","year":"2001","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"11","key":"10.1016\/B978-0-08-100094-6.00020-1_bib2","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1002\/jps.23266","article-title":"Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of anin vitro-in vivoscaling methodology for the blood\u2013brain barrier permeability of two transporter substrates, morphine and oxycodone","volume":"101","author":"Ball","year":"2012","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/B978-0-08-100094-6.00020-1_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1208\/s12248-013-9496-0","article-title":"Physiologically based pharmacokinetic modelling of drug penetration across the blood\u2013brain barrier\u2013towards a mechanistic IVIVE-based approach","volume":"15","author":"Ball","year":"2013","journal-title":"AAPS Journal"},{"issue":"3","key":"10.1016\/B978-0-08-100094-6.00020-1_bib4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/mp400533q","article-title":"A physiologically based modeling strategy during preclinical CNS drug development","volume":"11","author":"Ball","year":"2014","journal-title":"Molecular Pharmaceutics"},{"issue":"4","key":"10.1016\/B978-0-08-100094-6.00020-1_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/dmd.106.014027","article-title":"The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools","volume":"35","author":"De Buck","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/dmd.107.017434","article-title":"In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system","volume":"36","author":"Feng","year":"2008","journal-title":"Drug Metabolism and Disposition"},{"issue":"1\u20133","key":"10.1016\/B978-0-08-100094-6.00020-1_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-3659(02)00356-5","article-title":"Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3","volume":"87","author":"Florea","year":"2003","journal-title":"Journal of Controlled Release"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejpb.2005.02.010","article-title":"Human respiratory epithelial cell culture for drug delivery applications","volume":"60","author":"Forbes","year":"2005","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"8","key":"10.1016\/B978-0-08-100094-6.00020-1_bib9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1365-4362.1999.00782.x","article-title":"Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy","volume":"38","author":"Franz","year":"1999","journal-title":"International Journal of Dermatology"},{"issue":"3","key":"10.1016\/B978-0-08-100094-6.00020-1_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0169-409X(02)00013-3","article-title":"Physiologically-based pharmacokinetic simulation modelling","volume":"54","author":"Grass","year":"2002","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1\u20132","key":"10.1016\/B978-0-08-100094-6.00020-1_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2010.09.016","article-title":"Comparison of in vitro cell models in predicting in vivo brain entry of drugs","volume":"402","author":"Hakkarainen","year":"2010","journal-title":"International Journal of Pharmaceutics"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejpb.2012.07.020","article-title":"Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood\u2013brain barrier penetration models","volume":"82","author":"Hellinger","year":"2012","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"6","key":"10.1016\/B978-0-08-100094-6.00020-1_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/00498250600683197","article-title":"Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability","volume":"36","author":"Howgate","year":"2006","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/B978-0-08-100094-6.00020-1_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00498250600683262","article-title":"Prediction of in vivo drug clearance from in vitro data. II: potential inter-ethnic differences","volume":"36","author":"Inoue","year":"2006","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00020-1_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/js9803205","article-title":"MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening","volume":"88","author":"Irvine","year":"1999","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00020-1_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2133\/dmpk.24.53","volume":"24","author":"Jamei","year":"2009","journal-title":"Drug Metabolism and Pharmacokinetics"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","article-title":"Population-based mechanistic prediction of oral drug absorption","volume":"11","author":"Jamei","year":"2009","journal-title":"AAPS Journal"},{"issue":"3","key":"10.1016\/B978-0-08-100094-6.00020-1_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejpb.2011.11.009","article-title":"In vitro vs. in vivo tape stripping: validation of the porcine ear model and penetration assessment of novel sucrose stearate emulsions","volume":"80","author":"Klang","year":"2012","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"12","key":"10.1016\/B978-0-08-100094-6.00020-1_bib19","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1007\/s11095-014-1439-7","article-title":"Assessing topical bioavailability and bioequivalence: a comparison of the in vitro permeation test and the vasoconstrictor assay","volume":"31","author":"Lehman","year":"2014","journal-title":"Pharmaceutical Research"},{"issue":"5","key":"10.1016\/B978-0-08-100094-6.00020-1_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/A:1012121632357","article-title":"Jejunal permeability: a comparison between the Ussing chamber technique and the single-pass perfusion in humans","volume":"14","author":"Lennernas","year":"1997","journal-title":"Pharmaceutical Research"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system","volume":"58","author":"Lindenberg","year":"2004","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00020-1_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/dmd.32.1.132","article-title":"Development of a computational approach to predict blood\u2013brain barrier permeability","volume":"32","author":"Liu","year":"2004","journal-title":"Drug Metabolism and Disposition"},{"issue":"5","key":"10.1016\/B978-0-08-100094-6.00020-1_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejps.2005.07.010","article-title":"Drug permeability in 16HBE14o- airway cell layers correlates with absorption from the isolated perfused rat lung","volume":"26","author":"Manford","year":"2005","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1021\/jm049711o","article-title":"Exploring the role of different drug transport routes in permeability screening","volume":"48","author":"Matsson","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"issue":"11","key":"10.1016\/B978-0-08-100094-6.00020-1_bib25","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/jps.1120","article-title":"Pharmacokinetic models of dermal absorption","volume":"90","author":"McCarley","year":"2001","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00020-1_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1208\/s12249-014-0194-8","article-title":"Application of absorption modeling to predict bioequivalence outcome of two batches of etoricoxib tablets","volume":"16","author":"Mitra","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/B978-0-08-100094-6.00020-1_bib27","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1007\/s11095-010-0250-3","article-title":"Bioequivalence for topical products\u2014an update","volume":"27","author":"Narkar","year":"2010","journal-title":"Pharmaceutical Research"},{"issue":"10","key":"10.1016\/B978-0-08-100094-6.00020-1_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2165\/00003088-200342100-00002","article-title":"Whole body pharmacokinetic models","volume":"42","author":"Nestorov","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17425255.3.2.235","article-title":"Whole-body physiologically based pharmacokinetic models","volume":"3","author":"Nestorov","year":"2007","journal-title":"Expert Opinion on Drug Metabolism and Toxicology"},{"issue":"1\u20132","key":"10.1016\/B978-0-08-100094-6.00020-1_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2012.03.019","article-title":"Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model","volume":"429","author":"Paixao","year":"2012","journal-title":"International Journal of Pharmaceutics"},{"issue":"12","key":"10.1016\/B978-0-08-100094-6.00020-1_bib31","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1007\/s11095-014-1464-6","article-title":"In vitro cerebrovascular modeling in the 21st century: current and prospective technologies","volume":"31","author":"Palmiotti","year":"2014","journal-title":"Pharmaceutical Research"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib32","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(25)13060-7","article-title":"Comparison of in vitro and in vivo models of drug transcytosis through the blood\u2013brain barrier","volume":"253","author":"Pardridge","year":"1990","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"10.1016\/B978-0-08-100094-6.00020-1_bib33","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/jps.20419","article-title":"An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery","volume":"94","author":"Parrott","year":"2005","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"7","key":"10.1016\/B978-0-08-100094-6.00020-1_bib34","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/jps.23155","article-title":"Prediction of concentration-time profile and its inter-individual variability following the dermal drug absorption","volume":"101","author":"Polak","year":"2012","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/B978-0-08-100094-6.00020-1_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2014.01.018","article-title":"Quantification of nanoparticle uptake into hair follicles in pig ear and human forearm","volume":"179","author":"Raber","year":"2014","journal-title":"Journal of Controlled Release"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/toxsci\/kfn125","article-title":"Inhalation dosimetry modeling with decamethylcyclopentasiloxane in rats and humans","volume":"105","author":"Reddy","year":"2008","journal-title":"Toxicological Sciences"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd2173","article-title":"Simulation and prediction of in vivo drug metabolism in human populations from in vitro data","volume":"6","author":"Rostami-Hodjegan","year":"2007","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6","key":"10.1016\/B978-0-08-100094-6.00020-1_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jps.2600760608","article-title":"In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method","volume":"76","author":"Rougier","year":"1987","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00020-1_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1208\/ps060106","article-title":"Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown university, Washington, DC, may 29-30, 2002)","volume":"6","author":"Rowland","year":"2004","journal-title":"AAPS Journal"},{"issue":"9\u201310","key":"10.1016\/B978-0-08-100094-6.00020-1_bib40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.addr.2006.07.012","article-title":"In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery","volume":"58","author":"Sakagami","year":"2006","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/B978-0-08-100094-6.00020-1_bib41","series-title":"Drug absorption studies","first-page":"3","article-title":"Models for skin absorption and skin toxicity testing","author":"Schaefer","year":"2008"},{"year":"2012","author":"Silva","series-title":"Modelling and simulation in bioequivalence","key":"10.1016\/B978-0-08-100094-6.00020-1_bib42"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00020-1_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-013-1124-2","article-title":"Challenges of using in vitro data for modeling p-glycoprotein efflux in the blood\u2013brain barrier","volume":"31","author":"Sj\u00f6stedt","year":"2013","journal-title":"Pharmaceutical Research"},{"issue":"5","key":"10.1016\/B978-0-08-100094-6.00020-1_bib44","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.compbiomed.2006.06.004","article-title":"A computer model for the clearance of insoluble particles from the tracheobronchial tree of the human lung","volume":"37","author":"Sturm","year":"2007","journal-title":"Computers in Biology and Medicine"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00020-1_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.107.121525","article-title":"Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction","volume":"322","author":"Summerfield","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/B978-0-08-100094-6.00020-1_bib46","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1124\/jpet.105.092916","article-title":"Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain","volume":"316","author":"Summerfield","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"10.1016\/B978-0-08-100094-6.00020-1_bib47","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharmaceutical Research"},{"issue":"1\u20132","key":"10.1016\/B978-0-08-100094-6.00020-1_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-4274(02)00374-0","article-title":"Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection","volume":"138","author":"Theil","year":"2003","journal-title":"Toxicology Letters"},{"issue":"1","key":"10.1016\/B978-0-08-100094-6.00020-1_bib49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/1061186031000086117","article-title":"Drug absorption from the isolated perfused rat lung\u2013correlations with drug physicochemical properties and epithelial permeability","volume":"11","author":"Tronde","year":"2003","journal-title":"Journal of Drug Targeting"},{"issue":"7","key":"10.1016\/B978-0-08-100094-6.00020-1_bib50","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/js980236p","article-title":"General solution for diffusion-controlled dissolution of spherical particles. 1. theory","volume":"88","author":"Wang","year":"1999","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"7","key":"10.1016\/B978-0-08-100094-6.00020-1_bib51","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/mp500046f","article-title":"In vitro models of the blood\u2013brain barrier for the study of drug delivery to the brain","volume":"11","author":"Wilhelm","year":"2014","journal-title":"Molecular Pharmaceutics"},{"issue":"9","key":"10.1016\/B978-0-08-100094-6.00020-1_bib52","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1023\/A:1011930411574","article-title":"Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds","volume":"15","author":"Yazdanian","year":"1998","journal-title":"Pharmaceutical Research"},{"issue":"2","key":"10.1016\/B978-0-08-100094-6.00020-1_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(99)00147-7","article-title":"A compartmental absorption and transit model for estimating oral drug absorption","volume":"186","author":"Yu","year":"1999","journal-title":"International Journal of Pharmaceutics"},{"issue":"3","key":"10.1016\/B978-0-08-100094-6.00020-1_bib54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0169-409X(96)00009-9","article-title":"Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption","volume":"19","author":"Yu","year":"1996","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"6","key":"10.1016\/B978-0-08-100094-6.00020-1_bib55","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jps.1031","article-title":"Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors","volume":"90","author":"Zhao","year":"2001","journal-title":"Journal of Pharmaceutical Sciences"}],"container-title":["Concepts and Models for Drug Permeability Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780081000946000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780081000946000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T22:17:09Z","timestamp":1748643429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780081000946000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780081000946"],"references-count":55,"URL":"https:\/\/doi.org\/10.1016\/b978-0-08-100094-6.00020-1","relation":{},"subject":[],"published":{"date-parts":[[2016]]}}}